Effect of mirtazapine for benzodiazepines use compared with selective serotonin reuptake inhibitors in patients with major depressive disorder: A multicenter, open-label, randomized, controlled trial

被引：0
|
作者：
Hashimoto, T. [1 ]
Shiina, A. [2 ]
Hasegawa, T. [2 ]
Kimura, H. [3 ]
Niitsu, T. [1 ]
Tachibana, M. [4 ]
Muneoka, K. [5 ]
Matsuki, S. [1 ]
Nakazato, M. [1 ]
Shiraishi, T. [1 ]
Iyo, M. [1 ]
机构：
[1] Chiba Univ, Chiba, Japan
[2] Chiba Univ, Kokoronokenko Clin Tsudanuma, Chiba, Japan
[3] Chiba Univ, Kokoronokaze Clin, Chiba, Japan
[4] Fujita Hosp, Chiba, Japan
[5] Kimura Hosp, Chiba, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [21] Mirtazapine augmentation in treatment-resistant major depressive disorder: an open-label, six-week trial
    Aydemir, O
    Taskin, EO
    Deveci, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S401 - S402
  • [22] Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors
    Konuk, Numan
    Atasoy, Nuray
    Atik, Levent
    Akay, Omer
    ADVANCES IN THERAPY, 2006, 23 (04) : 646 - 654
  • [23] Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors
    Numan Konuk
    Nuray Atasoy
    Levent Atik
    Ömer Akay
    Advances in Therapy, 2006, 23 : 646 - 654
  • [24] An open study of triiodothyronine augmentation of selective serotonin Reuptake inhibitors in treatment-resistant major depressive disorder
    Iosifescu, DV
    Nierenberg, AA
    Mischoulon, D
    Perlis, RH
    Papakostas, GI
    Ryan, JL
    Alpert, JE
    Fava, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 1038 - 1042
  • [25] Emotional blunting with bupropion and serotonin reuptake inhibitors in three randomized controlled trials for acute major depressive disorder
    Peters, Evyn M.
    Balbuena, Lloyd
    Lodhi, Rohit J.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 : 29 - 32
  • [26] An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder
    Berk, M
    duPlessis, AD
    Birkett, M
    Richardt, D
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (03) : 137 - 140
  • [27] Selective Serotonin Reuptake Inhibitor and Venlafaxine Use in Children and Adolescents With Major Depressive Disorder: A Systematic Review of Published Randomized Controlled Trials
    Courtney, Darren B.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2004, 49 (08): : 557 - 563
  • [28] Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: An open-label case series
    Weiss, EL
    Potenza, MN
    McDougle, CJ
    Epperson, CN
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (08) : 524 - 527
  • [29] Efficacy of duloxetine and selective serotonin reuptake inhibitors - Comparisons as assessed by remission rates in patients with major depressive disorder
    Thase, Michael E.
    Pritchett, Yili Lu
    Ossanna, Melissa J.
    Swindle, Ralph W.
    Xu, Jimmy
    Detke, Michael J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (06) : 672 - 676
  • [30] Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
    Amare, Azmeraw T.
    Schubert, Klaus Oliver
    Tekola-Ayele, Fasil
    Hsu, Yi-Hsiang
    Sangkuhl, Katrin
    Jenkins, Gregory
    Whaley, Ryan M.
    Barman, Poulami
    Batzler, Anthony
    Altman, Russ B.
    Arolt, Volker
    Brockmoeller, Juergen
    Chen, Chia-Hui
    Domschke, Katharina
    Hall-Flavin, Daniel K.
    Hong, Chen-Jee
    Illi, Ari
    Ji, Yuan
    Kampman, Olli
    Kinoshita, Toshihiko
    Leinonen, Esa
    Liou, Ying-Jay
    Mushiroda, Taisei
    Nonen, Shinpei
    Skime, Michelle K.
    Wang, Liewei
    Kato, Masaki
    Liu, Yu-Li
    Praphanphoj, Verayuth
    Stingl, Julia C.
    Bobo, William V.
    Tsai, Shih-Jen
    Kubo, Michiaki
    Klein, Teri E.
    Weinshilboum, Richard M.
    Biernacka, Joanna M.
    Baune, Bernhard T.
    FRONTIERS IN PSYCHIATRY, 2018, 9
12345